Detailed Result for NCT04531865
NCT ID: | NCT04531865 |
---|---|
NLM Download Date Description: | N/A |
Study First Submitted Date: | 2020-08-26 |
Last Update Submitted Date: | 2020-12-25 |
Last Update Submitted Date: | 2020-12-25 |
Result First Submitted Date: | N/A |
Disposition First Submitted Date: | N/A |
Start Month Year: | January 1, 2021 |
Start Date: | 2021-01-01 |
Start Date Type: | Anticipated |
Verification Month Year: | December 2020 |
Verification Date: | 2020-12-31 |
Completion Month Year: | October 1, 2022 |
Completion Date: | 2022-10-01 |
Completion Date Type: | Anticipated |
Primary Completion Month Year: | September 1, 2022 |
Primary Completion Date: | 2022-09-01 |
Primary Completion Date Type: | Anticipated |
Study first Submitted QC Date: | 2020-08-26 |
Study first posted Date: | 2020-08-31 |
Result first Submitted QC Date: | N/A |
Result First Posted Date: | N/A |
Disposition First Submitted QC Date: | N/A |
Disposition First Posted Date: | N/A |
Last Updated Submitted QC Date: | 2020-12-25 |
Last Updated Posted Date: | 2020-12-29 |
Target Duration: | N/A |
Study Type: | Interventional |
Acronym: | N/A |
Baseline Population: | N/A |
Brief Title: | Randomized Trial Evaluating Mycophenolate Mofetil in Children With Nephrotic Syndrome After Rituximab Treatment |
Official Title: | Efficacy and Safety of Mycophenolate Mofetil as Maintenance Therapy After Rituximab Treatment in Childhood-onset, Frequently-relapsing or Steroid-dependent Nephrotic Syndrome: a Multicenter Double-blind, Randomized, Placebo-controlled Trial |
Overall Status: | Withdrawn |
Last Known Status: | N/A |
Phase: | Phase 3 |
Enrollment: | N/A |
Enrollment Type: | Actual |
Source: | Children's Hospital of Fudan University |
Limitation and Caveats: | N/A |
Number of Arms: | 2 |
Number of Groups: | N/A |
Why Stopped: | lack of funding |
Has Expanded Access: | N/A |
Expanded Access Type Individual: | N/A |
Expanded Access Type Intermediate: | N/A |
Expanded Access Type Treatment: | N/A |
Has DMC: | N/A |
Is it FDA Regulated Drug: | N/A |
Is it FDA Regulated Device: | N/A |
Is it Unapproved Device: | N/A |
Is PPSD: | N/A |
Is US Export: | N/A |
Is Biospec Retention: | N/A |
Biospec Description: | N/A |
Plan to Share IPD: | N/A |
Plan to Share IPD Description: | N/A |
IPD Time Frame: | N/A |
IPD Access Criteria: | N/A |
IPD URL: | N/A |